Generics Industry Urges Fed. Circ. To Fix Arthrex 'Disarray'
The generic-drug industry and a group of New York intellectual property lawyers have urged the full Federal Circuit to reconsider a panel's decision that Patent Trial and Appeal Board judges have...To view the full article, register now.
Already a subscriber? Click here to view full article